Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
J Zhejiang Univ Sci B ; 24(10): 935-942, 2023 Oct 15.
Article in English | MEDLINE | ID: mdl-37752094

ABSTRACT

Lung cancer remains the leading cause of cancer deaths worldwide and is the most common cancer in males. Immune-checkpoint inhibitors (ICIs) that target programmed cell death protein-1 (PD-1) or programmed cell death-ligand 1 (PD-L1) have achieved impressive efficacy in the treatment of non-small-cell lung cancer (NSCLC) (Pardoll, 2012; Champiat et al., 2016; Gao et al., 2022). Although ICIs are usually well tolerated, they are often accompanied by immune-related adverse events (irAEs) (Doroshow et al., 2019). Non-specific activation of the immune system produces off-target immune and inflammatory responses that can affect virtually any organ or system (O'Kane et al., 2017; Puzanov et al., 2017). Compared with adverse events caused by chemotherapy, irAEs are often characterized by delayed onset and prolonged duration and can occur in any organ at any stage of treatment, including after cessation of treatment (Puzanov et al., 2017; von Itzstein et al., 2020). They range from rash, pneumonitis, hypothyroidism, enterocolitis, and autoimmune hepatitis to cardiovascular, hematological, renal, neurological, and ophthalmic irAEs (Nishino et al., 2016; Kumar et al., 2017; Song et al., 2020). Hence, we conducted a retrospective study to identify validated factors that could predict the magnitude of the risk of irAEs in patients receiving PD-1/PD-L1 inhibitors; our approach was to analyze the correlation between the clinical characteristics of patients at the start of treatment and relevant indicators such as hematological indices and the risk of developing irAEs. Then, we developed an economical, practical, rapid, and simple model to assess the risk of irAEs in patients receiving ICI treatment, as early as possible.


Subject(s)
Carcinoma, Non-Small-Cell Lung , Lung Neoplasms , Male , Humans , Carcinoma, Non-Small-Cell Lung/drug therapy , Lung Neoplasms/drug therapy , Immune Checkpoint Inhibitors/adverse effects , Programmed Cell Death 1 Receptor , Retrospective Studies , Apoptosis
2.
Article in English | MEDLINE | ID: mdl-23566278

ABSTRACT

A dietary survey was conducted over three consecutive days by using 24-hour dietary recall in the Pearl River Delta of South China to investigate the dietary consumption status. A total of 1702 food samples, 22 food groups, were collected, and aluminium concentrations of foods were determined by using ICP-MS. Weekly dietary exposure to aluminium of the average urban residents of South China was estimated to be 1.5 mg kg⁻¹ body weight, which amounted to 76% of the provisional tolerable weekly intake. Wheat-made products (53.5%) contributed most to the dietary exposure, followed by vegetables (12.2%). The high-level consumers' weekly exposure to aluminium was 11.1 mg kg⁻¹ body weight, which amounted to 407% of the provisional tolerable weekly intake. The results indicated that the general urban residents in South China might be safe from aluminium exposure, but the high-level consumers might be at some risk of aluminium exposure. The foods contributing to aluminium exposure were processed food with aluminium-containing food additives. It is necessary to take effective measures to control the overuse of aluminium-containing food additives.


Subject(s)
Aluminum/toxicity , Diet , Environmental Exposure , Urban Population , Aluminum/analysis , China , Humans , Mass Spectrometry
3.
Genome Biol ; 4(12): R78, 2003.
Article in English | MEDLINE | ID: mdl-14659015

ABSTRACT

BACKGROUND: Cycads are ancient seed plants (living fossils) with origins in the Paleozoic. Cycads are sometimes considered a 'missing link' as they exhibit characteristics intermediate between vascular non-seed plants and the more derived seed plants. Cycads have also been implicated as the source of 'Guam's dementia', possibly due to the production of S(+)-beta-methyl-alpha, beta-diaminopropionic acid (BMAA), which is an agonist of animal glutamate receptors. RESULTS: A total of 4,200 expressed sequence tags (ESTs) were created from Cycas rumphii and clustered into 2,458 contigs, of which 1,764 had low-stringency BLAST similarity to other plant genes. Among those cycad contigs with similarity to plant genes, 1,718 cycad 'hits' are to angiosperms, 1,310 match genes in gymnosperms and 734 match lower (non-seed) plants. Forty-six contigs were found that matched only genes in lower plants and gymnosperms. Upon obtaining the complete sequence from the clones of 37/46 contigs, 14 still matched only gymnosperms. Among those cycad contigs common to higher plants, ESTs were discovered that correspond to those involved in development and signaling in present-day flowering plants. We purified a cycad EST for a glutamate receptor (GLR)-like gene, as well as ESTs potentially involved in the synthesis of the GLR agonist BMAA. CONCLUSIONS: Analysis of cycad ESTs has uncovered conserved and potentially novel genes. Furthermore, the presence of a glutamate receptor agonist, as well as a glutamate receptor-like gene in cycads, supports the hypothesis that such neuroactive plant products are not merely herbivore deterrents but may also serve a role in plant signaling.


Subject(s)
Cycas/genetics , Expressed Sequence Tags , Amino Acids, Diamino/biosynthesis , Cyanobacteria Toxins , Cycadopsida/genetics , Cycas/metabolism , DNA, Complementary/chemistry , DNA, Complementary/genetics , Gene Library , Genes, Plant/genetics , Sequence Analysis, DNA , Signal Transduction/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...